EP3784672A4 - METFORMIN AND SITAGLIPITIN TABLET FORMULATIONS - Google Patents

METFORMIN AND SITAGLIPITIN TABLET FORMULATIONS Download PDF

Info

Publication number: EP3784672A4
Authority: EP; European Patent Office
Prior art keywords: sitaglipitin; metformin; tablet formulations; formulations; tablet
Prior art date: 2018-04-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

EP19834733.8A

Other languages

German (de)

French (fr)

Other versions

EP3784672A2 (en

Inventor

Ali Turkyilmaz

Seval Ataman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanovel Ilac Sanayi ve Ticaret AS

Original Assignee

Sanovel Ilac Sanayi ve Ticaret AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-04-27

Filing date

2019-03-25

Publication date

2022-03-30

2019-03-25Application filed by Sanovel Ilac Sanayi ve Ticaret ASfiledCriticalSanovel Ilac Sanayi ve Ticaret AS

2021-03-03Publication of EP3784672A2publicationCriticalpatent/EP3784672A2/en

2022-03-30Publication of EP3784672A4publicationCriticalpatent/EP3784672A4/en

StatusPendinglegal-statusCriticalCurrent

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EP19834733.8A2018-04-272019-03-25 METFORMIN AND SITAGLIPITIN TABLET FORMULATIONSPendingEP3784672A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
TR201806019		2018-04-27
PCT/TR2019/050190WO2020013777A2 (en)	2018-04-27	2019-03-25	Tablet formulations comprising metformin and sitagliptin

Publications (2)

Publication Number	Publication Date
EP3784672A2 EP3784672A2 (en)	2021-03-03
EP3784672A4true EP3784672A4 (en)	2022-03-30

Family

ID=69141601

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19834733.8APendingEP3784672A4 (en)	2018-04-27	2019-03-25	METFORMIN AND SITAGLIPITIN TABLET FORMULATIONS

Country Status (2)

Country	Link
EP (1)	EP3784672A4 (en)
WO (1)	WO2020013777A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2022074664A1 (en)*	2020-10-05	2022-04-14	V-Ensure Pharma Technologies Private Limited	An immediate release composition of sitagliptin hydrochloride
KR20230009020A (en)*	2021-07-08	2023-01-17	한미약품 주식회사	A composite tablet containing sitagliptin, dapagliflozin and metformin
CN114010612B (en)*	2021-11-24	2022-06-28	上海普康药业有限公司	Sitagliptin and metformin double-layer sustained release tablet and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100323011A1 (en)*	2008-03-04	2010-12-23	Nazaneen Pourkavoos	Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
EP3731828A2 (en)*	2017-12-28	2020-11-04	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080064701A1 (en)*	2007-04-24	2008-03-13	Ramesh Sesha	Anti-diabetic combinations
PE20090882A1 (en)	2007-07-19	2009-08-03	Takeda Pharmaceutical	SOLID PREPARATION INCLUDING ALLOGLIPTIN AND METFORMIN HYDROCHLORIDE
PE20140960A1 (en)	2008-04-03	2014-08-15	Boehringer Ingelheim Int	FORMULATIONS INVOLVING A DPP4 INHIBITOR
WO2013110085A1 (en)	2012-01-20	2013-07-25	Handa Pharmaceuticals, Llc	Oral dosage forms for delivering metformin and sitagliptin

2019
- 2019-03-25WOPCT/TR2019/050190patent/WO2020013777A2/enactiveApplication Filing
- 2019-03-25EPEP19834733.8Apatent/EP3784672A4/enactivePending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20100323011A1 (en)*	2008-03-04	2010-12-23	Nazaneen Pourkavoos	Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor
EP3731828A2 (en)*	2017-12-28	2020-11-04	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references ofWO2020013777A2*

Also Published As

Publication number	Publication date
WO2020013777A3 (en)	2020-04-09
EP3784672A2 (en)	2021-03-03
WO2020013777A2 (en)	2020-01-16

Publication	Publication Date	Title
IL284835A (en)	2021-08-31	Pharmaceutical combination containing TNO155 and ribociclib
DK3784283T3 (en)	2024-11-25	CANNABIDIO PREPARATIONS AND USES THEREOF
DK3565550T3 (en)	2021-01-18	PHARMACEUTICAL COMPOSITIONS INCLUDING MELOXICAM AND RIZATRIPTANE
DK3448386T3 (en)	2021-04-26	ISOQUINOLIN-3-YLCARBOXAMIDES AND MANUFACTURE AND USE THEREOF
DK3610005T3 (en)	2021-12-13	PEPTIDLIGASE AND ITS USE
DK3365368T3 (en)	2023-06-26	TGFBETA1-BINDING IMMUNOGLOBULINS AND USE THEREOF
IL277640A (en)	2020-11-30	Human and cellular BCMA antibody - BCMA-CAR
DK3357513T3 (en)	2023-11-27	PHARMACEUTICAL COMPOSITION AND USE THEREOF
EP3866789A4 (en)	2022-07-06	TYK2 INHIBITORS AND USES THEREOF
DK3412660T3 (en)	2020-11-30	Sulfonamide derivative and pharmaceutical composition containing the same
DK3514153T3 (en)	2021-09-27	PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE
EP3826721C0 (en)	2023-10-11	NAPHTHYRIDINE COMPOUNDS AND USES THEREOF
EP3723488A4 (en)	2021-10-20	THERAPEUTIC BACTERIOCINS
DK3638251T3 (en)	2024-05-13	BISPHOSPHOCINE GEL FORMULATIONS AND USES THEREOF
DK3399978T3 (en)	2020-11-16	ANTIPROLIFERATIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF AND USES
HUE063120T2 (en)	2023-12-28	LRRC33 inhibitors and their use
IL283900A (en)	2021-07-29	Pharmaceutical combinations
IL284514A (en)	2021-08-31	Halo-allylamine compounds and their use
DK3886820T3 (en)	2023-05-15	Capsule formulations
EP3758712A4 (en)	2021-12-15	CPG-AMPHIPHILES AND USES THEREOF
HUE060805T2 (en)	2023-04-28	Pyridinamine-pyridone and pyrimidinamine-pyridone compounds
EP4051246A4 (en)	2023-11-15	DUAL-LAYER EFFORTABLE TABLET FORMULATIONS WITH DAPAGLIFLOZIN AND METFORMIN
EP3737676A4 (en)	2021-09-15	ACETAL COMPOUNDS AND THERAPEUTIC USES THEREOF
IL276323A (en)	2020-09-30	4-methyldihydropyrimidinone compounds and pharmaceutical use thereof
DK3947375T3 (en)	2024-05-21	IMIDAZOLONYLQUINOLINE COMPOUNDS AND THERAPEUTIC USES THEREOF

Legal Events

Date	Code	Title	Description
2020-01-18	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2021-01-08	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE
2021-01-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text:ORIGINAL CODE: 0009012
2021-01-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text:STATUS: REQUEST FOR EXAMINATION WAS MADE
2021-03-03	17P	Request for examination filed	Effective date:20201027
2021-03-03	AK	Designated contracting states	Kind code of ref document:A2 Designated state(s):AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2021-03-03	AX	Request for extension of the european patent	Extension state:BA ME
2021-07-08	TPAC	Observations filed by third parties	Free format text:ORIGINAL CODE: EPIDOSNTIPA
2021-08-04	DAV	Request for validation of the european patent (deleted)
2021-08-04	DAX	Request for extension of the european patent (deleted)
2022-02-20	REG	Reference to a national code	Ref country code:DE Ref legal event code:R079 Free format text:PREVIOUS MAIN CLASS: C07D0487040000 Ipc:A61K0009200000
2022-03-30	A4	Supplementary search report drawn up and despatched	Effective date:20220224
2022-03-30	RIC1	Information provided on ipc code assigned before grant	Ipc:A61K 31/4985 20060101ALI20220220BHEP Ipc:A61K 31/155 20060101ALI20220220BHEP Ipc:A61K 9/24 20060101ALI20220220BHEP Ipc:A61K 9/20 20060101AFI20220220BHEP
2023-08-16	P01	Opt-out of the competence of the unified patent court (upc) registered	Effective date:20230708
2025-01-01	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name:SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
2025-01-08	RAP3	Party data changed (applicant data changed or rights of an application transferred)	Owner name:SANOVEL ILAC SANAYI VE TICARET A.S.

Movatterモバイル変換